-
1 week ago | 
contagionlive.com | John Parkinson
This week, Pennsylvania has been added to the list of states with a measles outbreak. Two more cases were diagnosed recently in Erie County, Pa which is in the western part of the state. There have been 5 confirmed cases reported in this county since late March.
-
1 week ago | 
contagionlive.com | John Parkinson
April 16, 2025Precision BioSciences received the designation for its gene editing therapy, PBGENE-HBV, developed to eliminate the root cause of chronic hepatitis B virus (HBV). The FDA granted a fast track designation to clinical stage gene editing company, Precision BioSciences, for its investigational gene therapy, PBGENE-HBV.
-
1 week ago | 
contagionlive.com | John Parkinson
Gepotidacin, which was FDA approved last month for uncomplicated urinary tract infections, was found to be efficacious against gonorrhea even slightly exceeding the standard treatment for the sexually transmitted infection (STI). The study’s results were published in The Lancet.
-
1 week ago | 
contagionlive.com | John Parkinson
In a recent Morbidity and Mortality Weekly Report (MMWR), investigators reported that the state of Alaska saw reductions in incidence rates of hepatitis C.
-
1 week ago | 
contagionlive.com | John Parkinson |Carl Schmid
Within the last couple of weeks, the Trump administration has continued its closure and restructuring of federal agencies and offices related to infectious diseases. The administration dismissed the entire staff of the HHS Office of Infectious Diseases & HIV Policy, along with staff from other offices including the HHS Office of Minority Health and the Policy and Data Division supporting the Ryan White HIV/AIDS Program.
-
2 weeks ago | 
contagionlive.com | John Parkinson
New data being presented at the upcoming ESCMID Global 2025 will show cefiderocol (Fetroja) had a higher clinical cure rate trend among patients who received cefiderocol for a documented infection (67.4%) or as empiric therapy (64.6%) as compared to those who received it as salvage therapy (58.2%).1 “These data suggest a trend towards worse clinical outcomes when the use of cefiderocol to treat gram-negative bacterial infections is reserved as a last line treatment option compared with those...
-
2 weeks ago | 
contagionlive.com | John Parkinson |Janeen Madan Keller
The Trump Administration’s proposed public health policy changes are occurring on 2 fronts: domestically and internationally. And these sweeping changes that are happening are widespread enough that they will affect everyone’s health to some degree. One example on the international front is the administration’s plan to stop funding Gavi, the Vaccine Alliance.
-
2 weeks ago | 
contagionlive.com | John Parkinson
April 9, 2025This open-label trial will compare the combination of the company’s therapies, bemnifosbuvir and ruzasvir, to another HCV combination regimen. Boston-based Atea Pharmaceuticals announced it had dosed the first patient for its C-BEYOND phase 3 trial in the US and Canada.
-
2 weeks ago | 
contagionlive.com | John Parkinson
Tuberculosis (TB) continues to be a global health burden.According to the World Health Organization, an estimated 10.8 million people contracted TB worldwide in 2023, and the disease is present in all countries and age groups.¹ A total of 1.25 million people died from TB in 2023, which likely makes it the world's leading cause of death from a single infectious agent, according to the WHO.¹Additionally, with high incidence rates comes the issue of resistance.
-
2 weeks ago | 
contagionlive.com | John Parkinson
At the end of January, the Trump Administration ordered a stop-work for all global health funding, which included the US President’s Emergency Plan for AIDS Relief (PEPFAR) program. This long-standing public health initiative, started by President George W. Bush, has played a critical role in addressing the HIV/AIDS epidemic, particularly in sub-Saharan Africa.
